TRI Treatment Research Institute: Science Over Addiction

SENIOR TRI INVESTIGATORS AND ADMINISTRATORS

Wharton-TRI Center on the Organization and Management of Addiction Treatment

A. Thomas McLellan, Ph.D., Co-Director. Best known for his pioneering introduction of the Addiction Severity Index and Treatment Services Review in the 1980s, McLellan later conceptualized data-driven measurement of treatment effectiveness, performance-based monitoring, and analysis of the nation’s substance abuse treatment system as an “industry” beset with the same organizational, staffing and funding problems overcome in other problem-plagued industries. Through his research and extensive knowledge of substance abuse treatment systems, McLellan has become a persuasive proponent of the view that addiction is a chronically relapsing condition, one that must be continually monitored and managed. McLellan has published more than 400 articles and chapters on addiction research and serves as Editor in Chief of the Journal of Substance Abuse Treatment. He serves on the editorial boards and as a reviewer of numerous medical and scientific journals, and is advisor to numerous government and nonprofit scientific organizations, including the Office of National Drug Control Policy, Research and Evaluation; the National Practice Laboratory of the American Psychiatric Association, the Swiss National Science Foundation, the World Health Organization, and the Greek government.

John Kimberly, Ph.D., Co-Director. John R. Kimberly is the Henry Bower Professor of Entrepreneurial Studies and Professor of Management, Health Care Systems, and Sociology at the Wharton School of the University of Pennsylvania. He is also Executive Director of Wharton’s Global Alliance with INSEAD. He holds a PhD from Cornell University (1970), along with a MS from Cornell University (1967), and a BA from Yale University (1964). His previous appointments were at Yale University, the University of Illinois, and Cornell University, while his visiting appointments have included Ecole Polytechnique, Paris; University of Paris-Dauphine; and Ecole Superieure en Sciences Economiques et Commerciales (ESSEC), Paris. From 1998-2002 he was also the Novartis Professor of Healthcare Management, INSEAD, and was responsible for launching INSEAD’s Healthcare Management Initiative. Dr. Kimberly has served as organizational consultant to several organizations in the public and private sectors: the Directorate for Science, Technology, and Industry, and the Directorate for Scientific Affairs of the Organization for Economic Cooperation and Development in Paris, France; the Office of Technology Assessment of the U.S. Congress; the Association of American Medical Colleges; the Robert Wood Johnson Foundation; the MacArthur Foundation; and the Institute of Medicine of the National Academy of Sciences. His recent professional leadership activities include service on the editorial boards of the British Journal of Management and the American Journal of Medical Quality. In the corporate and public sectors, Dr. Kimberly has served as board member of the following institutions: the Community Financial Bancorp; Wissahickon Hospice; Chestnut Hill HealthCare; The Bach Festival of Philadelphia; the St. Regis Foundation; and the Arto Monaco Historical Society.

Next page >>